Rls-0071, a dual-targeting anti-inflammatory peptide – biomarker findings from a first in human clinical trial

HIGHLIGHTS

• who: Jessica Goss from the Department of Research and Medical Affairs Norfolk, ReAlta Life Sciences, Norfolk, Virginia, USA have published the paper: RLS-0071, a dual-targeting anti-inflammatory peptide - biomarker findings from a first in human clinical trial, in the Journal: (JOURNAL) of March/28,/2022
• what: The authors report the safety and biomarker findings as well as the pharmacokinetics from the first in human trial with RLS-0071. The This study was conducted in Canada in accordance with the guidelines described in the Declaration of Helsinki and the CIOMS International Ethical demographics for . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.